Wells Fargo & Company Omeros Corp Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Omeros Corp stock. As of the latest transaction made, Wells Fargo & Company holds 27,403 shares of OMER stock, worth $116,462. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,403

Previous 23,784 15.22%

Holding current value

$116,462

Previous $82,000 35.37%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.04 - $4.23 $11,001 - $15,308	3,619 Added 15.22%	27,403 $111,000
Q1 2024 May 10, 2024	BUY	$2.88 - $4.89 $7,574 - $12,860	2,630 Added 12.43%	23,784 $82,000
Q4 2023 Feb 09, 2024	BUY	$1.08 - $3.63 $3,949 - $13,274	3,657 Added 20.9%	21,154 $69,000
Q3 2023 Nov 13, 2023	SELL	$2.81 - $5.69 $28,701 - $58,117	-10,214 Reduced 36.86%	17,497 $51,000
Q2 2023 Aug 15, 2023	BUY	$4.45 - $7.57 $105,362 - $179,234	23,677 Added 586.94%	27,711 $150,000
Q1 2023 May 12, 2023	SELL	$2.48 - $5.22 $726 - $1,529	-293 Reduced 6.77%	4,034 $18,000
Q4 2022 Feb 13, 2023	SELL	$1.75 - $3.96 $6,457 - $14,612	-3,690 Reduced 46.03%	4,327 $9,000
Q3 2022 Nov 14, 2022	SELL	$3.09 - $7.46 $6,498 - $15,688	-2,103 Reduced 20.78%	8,017 $24,000
Q2 2022 Aug 12, 2022	SELL	$1.92 - $6.28 $13,921 - $45,536	-7,251 Reduced 41.74%	10,120 $27,000
Q1 2022 May 16, 2022	SELL	$5.07 - $7.2 $105,004 - $149,119	-20,711 Reduced 54.39%	17,371 $105,000
Q4 2021 Feb 14, 2022	BUY	$5.67 - $8.54 $86,189 - $129,816	15,201 Added 66.44%	38,082 $244,000
Q3 2021 Nov 15, 2021	SELL	$13.4 - $16.3 $157,945 - $192,128	-11,787 Reduced 34.0%	22,881 $316,000
Q2 2021 Aug 16, 2021	SELL	$14.81 - $19.13 $53,982 - $69,728	-3,645 Reduced 9.51%	34,668 $515,000
Q1 2021 May 13, 2021	SELL	$14.52 - $23.53 $1.24 Million - $2.01 Million	-85,401 Reduced 69.03%	38,313 $682,000
Q4 2020 Feb 09, 2021	BUY	$10.14 - $15.19 $165,515 - $247,946	16,323 Added 15.2%	123,714 $1.77 Million
Q3 2020 Nov 05, 2020	SELL	$9.57 - $21.32 $102,092 - $227,441	-10,668 Reduced 9.04%	107,391 $1.09 Million
Q2 2020 Aug 13, 2020	BUY	$12.21 - $16.99 $159,169 - $221,481	13,036 Added 12.41%	118,059 $1.74 Million
Q1 2020 May 14, 2020	BUY	$9.03 - $19.72 $948,357 - $2.07 Million	105,023 New	105,023 $1.4 Million

Others Institutions Holding OMER

# of Institutions

113

Shares Held

25.5M

Call Options Held

317K

Put Options Held

556K

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $267M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Omeros Corp Transaction History